Results 1 to 10 of about 3,235 (130)

Anti-Laminin 332-Type Mucous Membrane Pemphigoid [PDF]

Biomolecules, 2022
Anti-laminin (LM) 332-type mucous membrane pemphigoid (MMP) is a rare autoimmune bullous disease and was originally discovered as anti-epiligrin cicatricial pemphigoid.
Luhuai Shi, Xiaoguang Li, Hua Qian
doaj   +4 more sources

Mucous Membrane Pemphigoid in a Nonagenarian: A Case Report [PDF]

Annals of Geriatric Medicine and Research, 2023
Mucous membrane pemphigoid is a rare autoimmune blistering disease characterized by post-bullous erosion of mucous membranes. Herein, we present a case of a nonagenarian man who was referred to our department of dermatology presenting with painful ...
Océane Babin de Lignac, Priscille Carvalho, Marion Carrette, Lucie Cellier, Philippe Courville, Billal Tedbirt   +5 more
doaj   +2 more sources

Evaluation of the Diagnostic Value of Oesophageal Biopsies for Direct Immunofluorescence Microscopy in Mucous Membrane Pemphigoid [PDF]

Acta Dermato-Venereologica, 2023
Mucous membrane pemphigoid is an autoimmune blistering disorder characterized by predominant involvement of surface-close epithelia and linear depositions of immunoreactants at the dermal-epithelial junction on direct immunofluorescence microscopy.
Kaan Yilmaz, Onur Dikmen, Nina van Beek, Jens U. Marquardt, Martha M. Kirstein, Detlef Zillikens, Enno Schmidt   +6 more
doaj   +2 more sources

Tocilizumab for severe and refractory mucous membrane pemphigoid. [PDF]

J Eur Acad Dermatol Venereol
Elevated IL‐6 levels identified in mucous membrane pemphigoid support IL‐6 blockade, with tocilizumab demonstrating clinical benefit in nine patients with severe and refractory mucous membrane pemphigoid. Abstract Background Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease involving mucous membranes with a potentially ...
Tedbirt B, Maho-Vaillant M, Gueudry J, Golinski ML, Marcaillou M, Bergeret B, Chambon G, Bouchetemble P, Bekri S, Tebani A, Maillard H, Morice C, Vautier A, Libert EP, Le Roux-Villet C, Carrette M, Boyer O, Hébert V, Calbo S, Gillibert A, Joly P.   +20 more
europepmc   +2 more sources

Mucous Membrane Pemphigoid After Anti-PD-1 Therapy: Risk-Stratified Management and Treatment Outcomes. [PDF]

Int J Dermatol
ABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Dienes S, Esfandiari N, Daveluy S.
europepmc   +2 more sources

Tofacitinib for refractory ocular mucous membrane pemphigoid

American Journal of Ophthalmology Case Reports, 2021
Purpose: To report the successful use of tofacitinib in the treatment of refractory ocular mucous membrane pemphigoid (MMP). Observations: Two patients with ocular MMP presented with refractory disease after failure of multiple therapies.
Hayley James, Grace L. Paley, Richard Brasington, Philip L. Custer, Todd P. Margolis, Michael A. Paley   +5 more
doaj   +3 more sources

Successful Treatment of Mucous Membrane Pemphigoid with Dupilumab: A Case Report [PDF]

Acta Dermato-Venereologica
is missing (Short communication)
Zhiyi Wang, Xiaojing Liu, Jing Ni, Yushuo Qi, Zhiqi Song, Yongjun Piao   +5 more
doaj   +2 more sources

Real-Time Experience of Abrocitinib for the Treatment of Mucous Membrane Pemphigoid: A Case Report [PDF]

Patient Preference and Adherence
Yan Teng, Mingyang Ren, Xianhong Yang, Wei Lu, Xiaohua Tao Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital of Hangzhou Medical College, Hangzhou, 310014, People’s
Teng Y, Ren M, Yang X, Lu W, Tao X
doaj   +2 more sources

Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients

Case Reports in Dermatology, 2022
Bullous pemphigoid is the most common acquired bullous disease with an autoimmune basis and a tendency to involve mostly old people. By rising incidence of diabetes all over the world, consumption of antidiabetes medications has also increased.
Kamran Balighi, Sama Heidari, Mohammadreza Kavyani, Kambiz Kamyab Hesari, Nasim Tootoonchi   +4 more
doaj   +1 more source

Esophageal Bullous Pemphigoid

European Journal of Case Reports in Internal Medicine, 2022
Bullous pemphigoid is a rare autoimmune dermatologic disease that usually occurs in the elderly. Mucous membrane lesions occur in about 10–35% of patients and are almost always limited to the oral mucous membrane.
Catarina Castelo Branco, Tomás Fonseca, Ricardo Marcos-Pinto   +2 more
doaj   +1 more source